Anecdotally, fatigue, altered mood, blunted emotion, and decreased ability to concentrate can develop after bilateral thoracic sympathectomies.
β-Adrenoceptor blockers are a mainstay of treatment for CPVT. An automated defibrillator may have to be implanted. Treatment for CPVT also includes left sympathectomy. Such treatment leaves open the theoretical possibilities of denervation supersensitivity of cardiac adrenoceptors and compensatory activation of the adrenomedullary hormonal system; however, plasma levels of catecholamines have not been assessed in CPVT with or without therapeutic cardiac denervation.Table 1.
Neurocardiologic disorders that feature abnormal catecholaminergic function
Disorders where abnormal catecholaminergic function is etiologic
Hypofunctional states without central neurodegeneration
Acute, primary Neurocardiogenic syncope
Spinal cord transection
Acute pandysautonomia
Sympathectomy
Acute,
secondary Drug-related (e.g., alcohol, tricyclic antidepressant, chemotherapy, opiate, barbiturates, benzodiazepines, sympatholytics, general anaesthesia)Seizures
Guillain–Barre syndrome
Alcohol
Chronic,
primaryPure autonomic failure
Horner's syndrome
Familial dysautonomia
Carotid sinus syncope
Adie's syndrome
Dopamine-β-hydroxylase deficiency
Sympathectomy